Mucopolysaccharidosis Type Ii Mps Ii clinical trials

Explore recruiting mucopolysaccharidosis type ii mps ii clinical trials.

Recruiting mucopolysaccharidosis type ii mps ii studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Mucopolysaccharidosis Type Ii Mps Ii trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2/3, Multicenter, Double-Blind, Randomized Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic or Non-Neuronopathic Mucopolysaccharidosis Type II

Belgium, Netherlands, Germany, France, Italy, Czechia +2 more

Phase II and Phase III (Integrated) EU CTIS Study details

An Open-Label Extension to Investigate the Long-Term Safety, Tolerability, and Efficacy of DNL310 in Patients With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007

Italy, Belgium, Sweden, Spain, Czechia, Germany +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 1/2, Multicenter, Open-Label Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of DNL310 in Pediatric Participants with Hunter Syndrome

Netherlands

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Mucopolysaccharidosis Type Ii Mps Ii trials by city

Mucopolysaccharidosis Type Ii Mps Ii in Toronto Mucopolysaccharidosis Type Ii Mps Ii in Vancouver Mucopolysaccharidosis Type Ii Mps Ii in Montreal Mucopolysaccharidosis Type Ii Mps Ii in Calgary Mucopolysaccharidosis Type Ii Mps Ii in Edmonton Mucopolysaccharidosis Type Ii Mps Ii in Ottawa Mucopolysaccharidosis Type Ii Mps Ii in Winnipeg Mucopolysaccharidosis Type Ii Mps Ii in Quebec City Mucopolysaccharidosis Type Ii Mps Ii in Hamilton Mucopolysaccharidosis Type Ii Mps Ii in Kitchener Mucopolysaccharidosis Type Ii Mps Ii in London Mucopolysaccharidosis Type Ii Mps Ii in Halifax Mucopolysaccharidosis Type Ii Mps Ii in New York Mucopolysaccharidosis Type Ii Mps Ii in Los Angeles Mucopolysaccharidosis Type Ii Mps Ii in Chicago Mucopolysaccharidosis Type Ii Mps Ii in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease